Pular para o conteúdo
Merck
  • Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS2-Modified Electrodes and Chemometrics.

Electrochemical Determination of Hydroxyurea in a Complex Biological Matrix Using MoS2-Modified Electrodes and Chemometrics.

Biomedicines (2020-12-31)
Remi Cazelles, Rajendra P Shukla, Russell E Ware, Alexander A Vinks, Hadar Ben-Yoav
RESUMO

Hydroxyurea, an oral medication with important clinical benefits in the treatment of sickle cell anemia, can be accurately determined in plasma with a transition metal dichalcogenide-based electrochemical sensor. We used a two-dimensional molybdenum sulfide material (MoS2) selectively electrodeposited on a polycrystalline gold electrode via tailored waveform polarization in the gold electrical double layer formation region. The electro-activity of the modified electrode depends on the electrical waveform parameters used to electro-deposit MoS2. The concomitant oxidation of the MoS2 material during its electrodeposition allows for the tuning of the sensor's specificity. Chemometrics, utilizing mathematical procedures such as principal component analysis and multivariable partial least square regression, were used to process the electrochemical data generated at the bare and the modified electrodes, thus allowing the hydroxyurea concentrations to be predicted in human plasma. A limit-of-detection of 22 nM and a sensitivity of 37 nA cm-2 µM-1 were found to be suitable for pharmaceutical and clinical applications.

MATERIAIS
Número do produto
Marca
Descrição do produto

Sigma-Aldrich
Iron(III) sulfate hydrate, 97%
Sigma-Aldrich
Hydroxyurea, 98%, powder
Sigma-Aldrich
L-Homocysteine, ≥98.0% (NT)